BEARD BROS PHARMS

Bill To Promote Research Into Psilocybin and MDMA Passes In Hawaii

Rising debates about psilocybin and MDMA use for therapeutic purposes give way to passing of new bill 

The legalization and growing popularity of cannabis, especially for medical use, has sparked interest and debate into the possible legalization of other substances, namely psychedelics such as psilocybin and MDMA. 

Over the years, there have been discussions about whether these substances are effective in treating conditions such as PTSD, depression, stress, and anxiety. However, there are concerns about how these substances will be regulated, whether they are readily available, and whether they are effective or detrimental to one’s health. As a result, the solution needed was a working group that would research and analyze these factors. 

Debated Effectiveness And Support Of Psilocybin-Based Therapy For The Treatment Of Mental Health Conditions 

During the hearing where the bill‘s fate was being decided, many of the members present expressed their strong support for the passing of the bill. Wyly Gray, executive director of Veterans of War, stated that he had significantly struggled with PTSD after returning home from deployments in Iraq and Afghanistan. He credited plant medicines as his only source of solace and healing; thus, he fully supported the bill being passed. 

Another notable point was brought up by Tia Hartsuck, executive director of the Governor’s Office of Wellness & Resilience. She highlighted the negative impact that COVID-19 had on our mental health and how these issues are still prevalent today. As a result, interventions and treatments for mental health disorders, whatever they may be, should be included in conversations relating to trauma. She and her organization strongly supported the bill and were interested in finding out the potential effectiveness of the therapeutic use of psilocybin.

This view was also supported by Niko Leverenz, board president of The Drug Policy Forum, who stated that Hawaii could greatly benefit from creating controlled and practical provisions for the use of psilocybin as a therapeutic tool for those who need it. 

Debated Effectiveness And Support Of Psilocybin-Based Therapy For The Treatment

Long-Awaited Passing Of The bill 

There are numerous bills that have been introduced in the Aloha State, one of them being the creation of a state working group to research and analyze the medicinal and therapeutic effectiveness of psilocybin or psilocybin-based products in treating conditions such as anxiety, depression, and PTSD. 

Along with this research, members of this working group would be tasked with developing a strategic plan to ensure that affordable therapeutic psilocybin and psilocybin-based products are readily available and easily accessible to adults aged 21 and older who need them. 

The bill was drafted in agreement with the fact that mental health conditions could be treated in various ways, including medication, psychosocial services, and therapeutic measures using psilocybin and MDMA, as these substances have been categorized as breakthrough therapies by the FDA.

Psychedelic Progress In Hawaii

This passing of bills relating to psychedelic use is a considerable milestone for Hawaii, which had a strict policy against drug usage. Under the new leadership of Governor Josh Green, things seem to be more hopeful, as he is an avid supporter of marijuana legalization. 

Since Hawaii has a shortage of medical professionals and programs, developing solid programs in line with psychedelic therapy is likely to be met with open arms. These systems must be put in place as Hawaiian residents do not have the option of receiving treatment in a neighboring state. This issue will likely fuel the psychedelic movement in Hawaii and achieve many of the residents’ long-awaited dreams. 

Several states have been prompted to consider and explore the decriminalization of psychedelics following the passing of the Haiwain bills:

  • In New Hampshire, a bill has been filed to legalize the possession and use of psychedelics like psilocybin and LSD for adults 21 years and older. 
  • The Utah Senate is considering a bill to allow people with PTSD, anxiety, or depression to receive professional psychedelic treatment. 
  • A West Virginia Representative Kayla Young filed a bill to remove psilocybin, marijuana and THC from the state’s list of controlled substances. 
  • Republican Missouri lawmakers introduced legislation that provides access to psilocybin for people with severe mental health issues. 

A Psychedelic Future 

With an increasing number of states relaxing and introducing psychedelic laws, the future of psychedelics is looking bright. Society is also continuing to educate itself on matters relating to mental illness and the various methods, both conventional and unconventional, of treating it. As a result, they are warming up to the idea of psychedelic therapy, a once taboo concept. 

Psychedelic Progress In Hawaii

Enjoyed that first hit? Come chill with us at the Friday Sesh for a freshly packed bowl of the week’s best cannabis news!

Leave a Reply

Your email address will not be published. Required fields are marked *

READ MORE CANNABIS NEWS
Archives
Categories

NYCA I MO I MA I COMN I OHNJ I ALAK I AZ I AR I CT I DE I FL I GA I HI I ID I IL I IN I IA I KS I KY I LA I ME I MD I MI I MS I MT I NE I NV I NH I NC I ND I OK I OR I PA I RI I SC I SD I TN I TX I UT I VT I VA I WA I  WV I WI I WY I

FINANCEMEDICALNATIONAL I VETERANSPOLITICSPSYCHEDELICS I EDWIN RUBIS I RETAIL SPOTLIGHT I INDUSTRY I EDUCATION I BUSINESS I CULTURE I  RECREATION I MEDICAL I CULTIVATION I MANUFACTURING I TECHNOLOGY I RESEARCH I INSIGHTS I 

Cannabis Education

What is CBC?